Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neck Lines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00805012
What this trial is testing

Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Seoul National University Hospital 96
Testing effectiveness (Phase 2)UnknownNCT01312311
What this trial is testing

Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
Samsung Medical Center 51
Testing effectiveness (Phase 2)Study completedNCT02559687
What this trial is testing

Study of Pembrolizumab (MK-3475) in Previously-Treated Participants With Advanced Carcinoma of the Esophagus or Esophagogastric Junction (MK-3475-180/KEYNOTE-180)

Who this might be right for
Esophageal CarcinomaEsophagogastric Junction Carcinoma
Merck Sharp & Dohme LLC 121
Testing effectiveness (Phase 2)Study completedNCT02499328
What this trial is testing

Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck

Who this might be right for
Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 340
Large-scale testing (Phase 3)UnknownNCT05576272
What this trial is testing

A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Qilu Pharmaceutical Co., Ltd. 460
Large-scale testing (Phase 3)Active Not RecruitingNCT06082167
What this trial is testing

Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Exelixis 600
Testing effectiveness (Phase 2)UnknownNCT05008237
What this trial is testing

Weekly Docetaxel Plus Cisplatin as First-line Chemotherapy in Metastatic Salivary Gland Cancer Patients : a Multicenter Phase II Study

Who this might be right for
Salivary Gland Cancer
Samsung Medical Center 42
Large-scale testing (Phase 3)WithdrawnNCT03881111
What this trial is testing

First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)-China Extension Study

Who this might be right for
Esophageal Neoplasms
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)UnknownNCT03830385
What this trial is testing

Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck

Who this might be right for
Squamous Cell Carcinoma Of The Head And Neck
Sun Yat-sen University 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT05807880
What this trial is testing

Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 59
Testing effectiveness (Phase 2)Looking for participantsNCT06718205
What this trial is testing

Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Zhengzhou University 112
Not applicableLooking for participantsNCT01005654
What this trial is testing

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

Who this might be right for
Endocrine TumorsThyroid NeoplasmsParathyroid Neoplasms+2 more
National Cancer Institute (NCI) 2,415
Testing effectiveness (Phase 2)Looking for participantsNCT07733180
What this trial is testing

A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCC

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaMetastatic Esophageal Squamous Cell Carcinoma
BeOne Medicines 30
Testing effectiveness (Phase 2)Looking for participantsNCT07485296
What this trial is testing

Effect of Postbiotics on Microbiota and Systemic Immunomodulation of Pembrolizumab as First-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (RM HNSCC)

Who this might be right for
Head & Neck Squamous Cell Carcinoma
Gruppo Oncologico del Nord-Ovest 45
Large-scale testing (Phase 3)Study completedNCT02358031
What this trial is testing

Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)

Who this might be right for
Recurrent Head and Neck CancerMetastatic Head and Neck Cancer
Merck Sharp & Dohme LLC 882
Not applicableActive Not RecruitingNCT05165264
What this trial is testing

Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Bristol-Myers Squibb 600
Testing effectiveness (Phase 2)UnknownNCT05865132
What this trial is testing

Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal Junction

Who this might be right for
Esophagus Squamous Cell Carcinoma
AIPING ZHOU 30
Large-scale testing (Phase 3)Study completedNCT05741034
What this trial is testing

Assess Adverse Events and Effectiveness of Injected JUVÉDERM® VOLITE™ Gel Filler for Change in Neck Lines in Adult Chinese Participants

Who this might be right for
Neck Lines
AbbVie 159
Not applicableUnknownNCT03619304
What this trial is testing

Assessment of Anti-cancerous Effect of Green, Roasted and Decaffeinated Coffee on Oral Squamous Cell Carcinoma Cell Line

Who this might be right for
Oral Squamous Cell Carcinoma
Cairo University 20
Testing effectiveness (Phase 2)UnknownNCT04503967
What this trial is testing

Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal Cancer

Who this might be right for
Gastric AdenocarcinomaEsophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 48
Next Page